Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR-3001 (Oxybutynin Vaginal Ring) in Women with Overactive Bladder
NCT00196404Phase 2Completed
- Sponsor
- Duramed Research
- Start
- Oct 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of oxybutynin in overactive bladder (OAB), urinary incontinence (UI), sponsored by Duramed Research. Started Oct 2004; status: completed.
02
Drugs
oxybutynin
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT00196404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196404.